The value of detecting pepsinogen and gastrin-17 levels in serum for pre-cancerous lesion screening in gastric cancer.

Yu, G; Wang, G X; Wang, H G; Mo, F F; Tang, B B

Yu, G; Wang, G X; Wang, H G; Mo, F F; Tang, B B.

Afiliação

Yu G; Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou University, Taizhou, China.
Wang GX; Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou University, Taizhou, China.
Wang HG; Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou University, Taizhou, China.
Mo FF; Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou University, Taizhou, China.
Tang BB; Department of Gastroenterology, Taizhou Municipal Hospital, Taizhou University, Taizhou, China.

Neoplasma ; 66(4): 637-640, 2019 Jul 23.

Article em En | MEDLINE | ID: mdl-31058531

Assuntos

Gastrinas/sangue; Pepsinogênio A/sangue; Pepsinogênio C/sangue; Neoplasias Gástricas/diagnóstico; Estudos de Casos e Controles; Detecção Precoce de Câncer; Humanos; Neoplasias Gástricas/sangue

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Neoplasias Gástricas / Gastrinas / Pepsinogênio A / Pepsinogênio C Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Neoplasma Ano de publicação: 2019 Tipo de documento: Article País de afiliação: China

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google